Canada markets open in 9 hours

Cryofocus Medtech (Shanghai) Co., Ltd. (6922.HK)

HKSE - HKSE Delayed Price. Currency in HKD
Add to watchlist
7.7700.000 (0.00%)
As of 10:17AM HKT. Market open.
Currency in HKD

Valuation Measures4

Market Cap (intraday) 1.86B
Enterprise Value 1.76B
Trailing P/E N/A
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)42.22
Price/Book (mrq)10.71
Enterprise Value/Revenue 39.96
Enterprise Value/EBITDA -50.38

Trading Information

Stock Price History

Beta (5Y Monthly) N/A
52-Week Change 3-55.34%
S&P500 52-Week Change 324.96%
52 Week High 319.500
52 Week Low 35.000
50-Day Moving Average 38.279
200-Day Moving Average 313.643

Share Statistics

Avg Vol (3 month) 314.19k
Avg Vol (10 day) 315.04k
Shares Outstanding 5114.1M
Implied Shares Outstanding 6239.11M
Float 822.22M
% Held by Insiders 180.84%
% Held by Institutions 14.31%
Shares Short 4N/A
Short Ratio 4N/A
Short % of Float 4N/A
Short % of Shares Outstanding 4N/A
Shares Short (prior month ) 4N/A

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Currency in CNY.

Fiscal Year

Fiscal Year Ends Dec 31, 2023
Most Recent Quarter (mrq)Dec 31, 2023

Profitability

Profit Margin -238.06%
Operating Margin (ttm)-298.42%

Management Effectiveness

Return on Assets (ttm)-28.43%
Return on Equity (ttm)-48.86%

Income Statement

Revenue (ttm)40.95M
Revenue Per Share (ttm)0.17
Quarterly Revenue Growth (yoy)30.80%
Gross Profit (ttm)N/A
EBITDA -114.35M
Net Income Avi to Common (ttm)-97.49M
Diluted EPS (ttm)-0.440
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)104.45M
Total Cash Per Share (mrq)0.44
Total Debt (mrq)11.01M
Total Debt/Equity (mrq)6.35%
Current Ratio (mrq)4.87
Book Value Per Share (mrq)0.68

Cash Flow Statement

Operating Cash Flow (ttm)-95.89M
Levered Free Cash Flow (ttm)-85.44M